HaemSTAR Collaborators[Corporate Author] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2021	1
2022	2
2023	1
2024	0

Page 1

Diagnostic uncertainty presented barriers to the timely management of acute thrombotic thrombocytopenic purpura in the United Kingdom between 2014 and 2019.

HaemSTAR Collaborators. HaemSTAR Collaborators. J Thromb Haemost. 2022 Jun;20(6):1428-1436. doi: 10.1111/jth.15681. Epub 2022 Mar 11. J Thromb Haemost. 2022. PMID: 35189012 Free PMC article.

A single 1 g/kg dose of intravenous immunoglobulin is a safe and effective treatment for immune thrombocytopenia; results of the first HaemSTAR 'Flash-Mob' retrospective study incorporating 961 patients.

HaemSTAR Collaborators. HaemSTAR Collaborators. Br J Haematol. 2022 Jan;196(2):433-437. doi: 10.1111/bjh.17692. Epub 2021 Dec 3. Br J Haematol. 2022. PMID: 34859421 No abstract available.

Re-evaluation of the risk of venous thromboembolism after COVID-19 vaccination using haematological criteria.

Shaw RJ, Doyle AJ, Millen EA, Stowe J, Tessier E, Andrews N, Miller E; HaemSTAR collaborators. Shaw RJ, et al. Vaccine. 2023 Aug 14;41(36):5330-5337. doi: 10.1016/j.vaccine.2023.06.006. Epub 2023 Jun 7. Vaccine. 2023. PMID: 37495490 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

3 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

3 results

Results by year